SCLR announces FDA's issue of deficiency letter for pseudoephedrine ANDA
Links shared publicly online about this topic.
- 440total visits
SCLR announces FDA's issue of deficiency letter for pseudoephedrine ANDA
SCOLR Pharma, Inc. today announced it has received a letter from the Food and Drug Administration identifying deficiencies regarding its Abbreviated New Drug Application for extended-release pseudoephedrine.
View full resource at news-medical.net
Tags: Diet and Nutrition, Drug, Pharma, FDA, Decongestant, Sudafed
Most Recently Shared on March 14, 2011 at 8:46 am By:
SCLR announces FDA's issue of deficiency letter for pseudoephedrine ANDA: SCOLR Pharma, Inc. today announced it ... http://bit.ly/hHckcr
Advertisement
